Highbridge Capital Management LLC Meridian Bioscience Inc Transaction History

Highbridge Capital Management LLC

  • $333 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$13.8 - $16.8 $313,577 - $381,746
-22,723 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$13.8 - $16.2 $313,577 - $368,112
22,723 New
22,723 $323,000
Q4 2017

Feb 14, 2018
SELL
$13.55 - $15.8 $211,298 - $246,385
-15,594 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$13.45 - $14.35 $209,739 - $223,773
15,594
15,594 $223,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Highbridge Capital Management LLC Portfolio

Follow Highbridge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highbridge Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email